Inhibitor Therapeutics, Inc. Number of Reportable Segments
Inhibitor Therapeutics, Inc. (INTI) reported Number of Reportable Segments of 1 Segment for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Notes › Segment Reporting
us-gaap:NumberOfReportableSegments · last filed 2026-08-14
- Inhibitor Therapeutics, Inc. number of reportable segments for fiscal 2024 was 1.00 Segment.
| Period end | Number of Reportable Segments 6 month | Number of Reportable Segments 12 month |
|---|---|---|
| 2026-06-30 | 1.00 Segment 10-Q · filed 2026-08-14 | |
| 2024-12-31 | 1.00 Segment 10-K · filed 2025-03-28 |